North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2026-2034
The North America hormone replacement therapy market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.2 Billion by 2034, exhibiting a growth rate (CAGR) of 4.29% during 2026-2034.
Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.
¬North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the North America hormone replacement therapy market report, along with forecasts at the regional and country level from 2026-2034. Our report has categorized the market based on product, route of administration and type of disease.
Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.
¬North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the North America hormone replacement therapy market report, along with forecasts at the regional and country level from 2026-2034. Our report has categorized the market based on product, route of administration and type of disease.
- Key Regions Analysed
- United States
- Canada
- Mexico
- Analysis for Each Country
- Market by Product
- Estrogen Replacement Therapy
- Human Growth Hormone Replacement Therapy
- Thyroid Replacement Therapy
- Testosterone Replacement Therapy
- Others
- Market by Route of Administration
- Oral
- Parenteral
- Transdermal
- Market by Type of Disease
- Menopause
- Hypothyroidism
- Male Hypogonadism
- Growth Hormone Deficiency
- Others
- Value Chain Analysis
- Key Drivers and Challenges
- Porters Five Forces Analysis
- PESTEL Analysis
- Government Regulations
- Competitive Landscape
- Competitive Structure
- Key Player Profiles
- How has the North America hormone replacement therapy market performed so far and how will it perform in the coming years?
- What are the key regions in the North America hormone replacement therapy market?
- What has been the impact of COVID-19 on the North America hormone replacement therapy market?
- What is the breakup of the North America hormone replacement therapy market on the basis of product?
- What is the breakup of the North America hormone replacement therapy market on the basis of route of administration?
- What is the breakup of the North America hormone replacement therapy market on the basis of type of disease?
- What are the various stages in the value chain of the North America hormone replacement therapy industry?
- What are the key driving factors and challenges in the North America hormone replacement therapy industry?
- What is the structure of the North America hormone replacement therapy industry and who are the key players?
- What is the degree of competition in the North America hormone replacement therapy industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HORMONE REPLACEMENT THERAPY MARKET
5.1 Market Performance
5.2 Market Breakup by Product
5.3 Market Breakup by Route of Administration
5.4 Market Breakup by Type of Disease
5.5 Market Breakup by Region
5.6 Market Forecast
6 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY PRODUCT
7.1 Estrogen Replacement Therapy
7.2 Human Growth Hormone Replacement Therapy
7.3 Thyroid Replacement Therapy
7.4 Testosterone Replacement Therapy
7.5 Others
8 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.2 Parenteral
8.3 Transdermal
9 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY TYPE OF DISEASE
9.1 Menopause
9.2 Hypothyroidism
9.3 Male Hypogonadism
9.4 Growth Hormone Deficiency
9.5 Others
10 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY COUNTRY
10.1 United States
10.1.1 Historical Market Trends
10.1.2 Market Breakup by Product
10.1.3 Market Breakup by Route of Administration
10.1.4 Market Breakup by Type of Disease
10.1.5 Market Forecast
10.2 Canada
10.2.1 Historical Market Trends
10.2.2 Market Breakup by Product
10.2.3 Market Breakup by Route of Administration
10.2.4 Market Breakup by Type of Disease
10.2.5 Market Forecast
10.3 Mexico
10.3.1 Historical Market Trends
10.3.2 Market Breakup by Product
10.3.3 Market Breakup by Route of Administration
10.3.4 Market Breakup by Type of Disease
10.3.5 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
12.1 Overview
12.2 Research and Development
12.3 Raw Material Procurement
12.4 Manufacturing
12.5 Marketing
12.6 Distribution
12.7 End-Use
13 PORTER’S FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Rivalry
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HORMONE REPLACEMENT THERAPY MARKET
5.1 Market Performance
5.2 Market Breakup by Product
5.3 Market Breakup by Route of Administration
5.4 Market Breakup by Type of Disease
5.5 Market Breakup by Region
5.6 Market Forecast
6 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY PRODUCT
7.1 Estrogen Replacement Therapy
7.2 Human Growth Hormone Replacement Therapy
7.3 Thyroid Replacement Therapy
7.4 Testosterone Replacement Therapy
7.5 Others
8 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY ROUTE OF ADMINISTRATION
8.1 Oral
8.2 Parenteral
8.3 Transdermal
9 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY TYPE OF DISEASE
9.1 Menopause
9.2 Hypothyroidism
9.3 Male Hypogonadism
9.4 Growth Hormone Deficiency
9.5 Others
10 NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET: BREAKUP BY COUNTRY
10.1 United States
10.1.1 Historical Market Trends
10.1.2 Market Breakup by Product
10.1.3 Market Breakup by Route of Administration
10.1.4 Market Breakup by Type of Disease
10.1.5 Market Forecast
10.2 Canada
10.2.1 Historical Market Trends
10.2.2 Market Breakup by Product
10.2.3 Market Breakup by Route of Administration
10.2.4 Market Breakup by Type of Disease
10.2.5 Market Forecast
10.3 Mexico
10.3.1 Historical Market Trends
10.3.2 Market Breakup by Product
10.3.3 Market Breakup by Route of Administration
10.3.4 Market Breakup by Type of Disease
10.3.5 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
12.1 Overview
12.2 Research and Development
12.3 Raw Material Procurement
12.4 Manufacturing
12.5 Marketing
12.6 Distribution
12.7 End-Use
13 PORTER’S FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Rivalry
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
